Oncology& Cancer Case Reports
Cancer is anuncontrolled division of cell which causes to death.Oncology & Cancer Case Reportsrefer to the study of the chemistry of cancer and tumorsat the molecular scale. Oncology depends on diagnostic tools likebiopsyor removal ofbits of thetumourtissueand endoscopy for thegastrointestinal tract, imaging studies like X-rays, CT scanning, MRI scanning,ultrasound and other radiological techniques, Scintigraphy.
Carcinoma is a kind ofcancer that grows from epithelial cells. Specifically, acarcinomaisa cancer that begins in a tissue that lines the inner or outer surfaces of thebody, and that generally arises from cells originating in the endodermal orectodermal germ layer duringembryogenesis.Carcinomas occur when the DNA of a cell is damaged or altered and the cellbegins to grow uncontrollably and become malignant.Carcinoma case reportrefersto the study of symptoms, signs, diagnosis, and treatment of the patientssuffering from carcinogenesis.
Cancer cells act asself-governing cells, growing without control to form tumors.Tumorsgrowin a series of steps. The first step ishyperplasia. Thesecells appear normal, but changes have occurred that result in some loss ofcontrol of growth. The second step is dysplasia, resulting from further growth,accompanied by abnormal changes to the cells. The third step requiresadditional changes, which result in cells that are even more abnormal and cannow spread over a wider area of tissue. These cells begin to lose theiroriginal function; such cells are calledanaplastic. The last stepoccurs when the cells in the tumor metastasize, which means that they caninvade surrounding tissue, including the bloodstream, and spread to otherlocations. This is the most serious type of tumor, but not all tumors progressto this point. Non-invasive tumors are said to be benign.
Clinical Trials& Oncology Reports
People withcancerarefrequently offered the option of treatment in a clinical trial. In a clinicaltrial, patients can be certain of receiving excellent treatment with thepossibility of receiving additional new treatments that could help them. Theirparticipation also helps contribute to improved treatments for futurepatients.Clinical trialsmay include hundredsor even thousands of people. That means it can take a long time to get results.This process is also on-going. As doctors learn and study new information, theyadd new care standards or replace old ones. Clinical trials are the onlyaccepted way scientists can find out if new treatments work better thanstandard ones.
Cancer Prognosis& Prevention
Cancer survivalratesor survival numbers tell the percentage of people who survive an assured typeof cancer for a specific amount of time.Cancerstatisticsoften use an overall five-year survival rate. Cancersurvival rates are maintained on research from information gathered on hundredsor thousands of individual with a particular cancer. An overall survival rateincludes individuals of all ages and health conditions who have been diagnosedtogether with cancer, together with those diagnosed terribly early and peoplediagnosed terribly late. Making the people educate about thecancercanprevent the death of the through cancer. There are many cancers which can becure at early stages.
Case Reports onSurgical Oncology
Surgical oncology isthe branch of surgery applied to oncology; it focuses on the surgicalmanagement of tumors, especially cancerous tumors. As one of some modalities inthe management of cancer, the specialty of surgical oncology, before modernmedicine the only cancer treatment with a chance of success, has grown inpoints similar tomedical oncology,which grew out ofhematology,and radiation oncology, which grew out of radiology. The proliferation ofcancer centers will continue to feast the field, as will developments inminimally invasive techniques, palliative surgery, and neo-adjuvant treatments
There is some cancerwhich is rarely found. According to the definition, rarecancersareidentified as those with an incidence of less than 6 per 100,000 persons peryear. Using this definition would help minimise the risk of mistaking a rarecancer such as testicular cancer, which is frequently cured and thus has arather high prevalence, for a common cancer, or a frequent cancer such assmall-cell lung cancer, which has a low life expectancy and thus a lowprevalence, for a rare cancer. Some of the examples of rare cancer are: Actiniccell adenocarcinoma of theparotid gland,Cervix small cell, Children cancers and chordoma.
ClinicalOncology & Radiation Oncology
Clinical oncologyconsists of three primary disciplines: medical oncology which refers to thetreatment of cancer with medicine, includingchemotherapy,surgical oncology which refers to the surgical aspects of cancerincludingbiopsy,staging, and surgical resection of tumors, andradiationoncologythe treatment of cancer with therapeutic radiation.These are the main disciplines which are used by the doctors to treat theoncology patients. Chemotherapy is well known method for the treatment ofcancer.
Nursing is one of themost important parts of medical care.Oncology nursespracticein a variety of settings, including hospitals,outpatient clinics, private practices, long-term care facilities and more. Thescope of oncology nursing spans from prevention and early detection, totreatment such as surgical oncology, radiation oncology,medical oncology,through symptom management and palliative care. Thoughtful for cancer patientsis very rewarding. Its also a physically, mentally and emotionally difficultjob. Oncology nurses must keep track of several details throughout the day foreach patient and they likely have to tend to several patients each day. Onemistake could adversely affect a patients health, so their attention to detailis critical.
Gynecologic Cancer isthe field of medicine that focuses on cancers of thefemale reproductive system.As experts they have wide training in the diagnosis and treatment of thiscancer. In 2012, there were about 4.7 million cases of women cancer worldwidein which 54% cases arose in less developed countries. Although the occurrenceand mortality fromGynecologiccancerare major, other cancers are very uncommon. Primarycancers of the vulva, vagina, placenta and adnexa total 0.6% of all womancancers. In the world 90,000 women are identified with Gynecologic Cancer eachyear. Early detection oftumour biologyandtreatment of Gynecologic Cancer in younger women is more as compared to olderwomen.
Hematologyadditionally spelled asHeamatology,is the division of medicine involved with the learning, diagnosis, treatment,and bar of diseases associated with the blood. Hematology includes the learningof etiology. It includes treating diseases that have an effect on the assemblyof blood and its components, like blood cells,blood proteins, bonemarrow,hemoglobin,platelets, blood vessels, spleen, and also the mechanism of clotting.Physicians focused in hematology are referred as Heamatologists. There arevaried disorders that people are affected by. Some of those dissimilar types ofblood conditions that are checked out embrace include anemia,hemophilia,general blood clots, bleeding disorders, etc. As for connected blood cancerssuch as leukemia, myeloma, and lymphoma, these are a lot of serious cases thatrequire to be diagnosed.
Canceris aleading cause of death worldwide, around 8.2 million deaths in 2012-2013. In2010, the global cancer market was valued around $55 billion, with forecastedCompound Annual Growth Rategrowth to approximate of $80 billion by 2016.The seven major cancer markets US, France, Italy, Spain, United Kingdom andJapan) represented around 80% of the 2010 globalcancer market(around$42 billion). The US dominated 2010 sales with a market share of 39.5% and theleading ten companies of the global cancer market represented 86.1% ($46billion) of the total market.
Reports onDifferential Diagnosis methods
Diagnostic testinginvolves tests and procedures to confirm the presence of disease and identifythe correcttumortype,location, extent and stage. There are many types of the diagnosis methods theyare as follows: Biopsy,Endoscopy,Pap test, imaging studies.Biopsyis a testwhere a small sample of tissue is taken from the suspectedcancerwith the helpof a fine tipped needle. The tissues are then examined under a microscope forthe presence of cancer cells. Endoscopy In this imaging technique a tinny,flexible tube with a tiny camera on the end is inserted into the body cavities.This allows the doctors to view the suspicious area. There are many types ofscopes, each designed to view particular areas of the body. Pap test Pap testis a routine test where a sample of cells from a womans cervix is examinedunder the microscope. This helps identify changes in the cells that couldindicate cervical cancer or other conditions. Imaging studies there are severalimaging techniques. These include X rays, CT scans,MRI scansofvarious parts of the body.X-raysarethe most common imaging techniques and they may be made more specific by usinga Barious enema. This is used for detection of stomach and small intestinalgrowths and cancers. Mammogram is an X-ray of the breasts used to screen forand/or detect breast lumps and growths. A CAT scan (computerized axialtomography) uses radiographic beams to create detailed computerized pictures.It is more precise than a standard X-ray.
There are some newdiagnostics methods which are uses by the doctors to treat the cancer they areas follow Linear Accelerators This technology is the platform forIMRTandIGRT, permits specialists to deposit variable amounts ofradiationina highly controlled fashion. The Linear Accelerator treatment machine uses acomputerized tool to shape the radiation beam in unity with the improvedtreatment plan. The implement can constantly move to change both the shape andintensity of the beam to fit each patient and each tumor size and form. IMRT(Intensity Modulated Radiation Therapy) Intensity Modulated Radiation Therapyoffers potential benefits for the treatment of many cancer types. Thetechnology enablesradiationoncologiststo bombard cancer cells with higher doses ofradiation than those previously delivered, while keeping exposure to the normaltissue at a minimum. Image Guided Radiation Therapy (IGRT) provides a uniquetreatment advantage: it has the potential to achieve both unparalleled tumorcontrol and normal tissue sparing. The radiation beam can be shaped to matchthe dimensions of a tumor and a high dose of radiation can be delivered to amalignancy without harming surrounding normal tissue.Tumorscanmove, both during a radiation treatment session and from one treatment sessionto another, as a result of normal internal organ action and small differencesin the way the patient is positioned for treatment. Three-Dimensional conformalRadiation Therapy Using the wide-boar CT simulator, a device that allowsphysicians to perform three-dimensional mapping for precision and pinpointtargeting of tumors, radiation oncologists can perform simulations with muchgreater speed (15-30 minutes vs. 1-3 hours needed for conventional simulation),and much greater comfort for the patient. High-Dose Rate Brachytherapy Anothermeans of delivering concentrated doses directly to the tumor site withoutaffecting adjacent tissues and organs, this method utilizes a catheter as themeans for theradioactivesourceto travel to the site.
Reports inInvestigation Studies
Carcinoma is a kind ofcancer that grows fromepithelial cells.Specifically, a carcinoma is a cancer that begins in a tissue that lines theinner or outer surfaces of the body, and that generally arises from cellsoriginating in the endodermal or ectodermal germ layer duringembryogenesis.Carcinomasoccurwhen the DNA of a cell is damaged or altered and the cell begins to growuncontrollably and become malignant.Carcinoma case reportrefersto the study of symptoms, signs, diagnosis, and treatment of the patientssuffering from carcinogenesis.
Cancer managementcoversthe risk factors, symptoms,diagnosis, staging,and treatment of the cancer. This is widely related to the care of the patientswhoever are suffering from cancer. This process is taking care of thecancerpatientsdaily activates. Its also dealing with the support emotionally to the cancerpatients.
Supportive Carein Oncology
Care given to expandthe quality of life of patients who have a serious or severe disease. The goalof supportive care is to prevent or treat as early as possible the symptoms ofa disease, side effects caused by treatment of a disease, andpsychological,social, and spiritual problems related to a disease or its treatment. Alsocalled comfort care, palliative care and symptom management. The SupportiveCare Centre accepts patients of allcancer diagnoses,at any point within their disease and/or treatment process. Its involves incare of physical or emotional symptoms, improving function and reducingdisability.
Toxicology and Cancer Biology
Toxicology andCancer Biologythesurvey is being done inecotoxicology,transmissible toxicology andCancer science.The Research Collection actively supports aspects of basic research intoenvironmental, human and animal health problems as they relate to thedisciplines ofToxicology andCancer Biology. The Research Cluster effectively underpins parts ofessential research into natural, human and animal medical problems as theyrecognize with the orders of Toxicology and Cancer Biology. Several issuesalong the U.S.-Mexico border relate to, but are by no means limited to heavymetal contamination and exposure, water pollution from both domestic andinternational sources, air pollution and the associated acute and chronicexposure to environmental contaminants originating from the deposition of smallmolecules that, collectively, pollute the air.
Cancer staging can bedivided into a clinical stage and apathologic stage.In the Tumor, Node, Metastasis system,clinical stageandpathologic stage are denoted by a small “c” or “p” beforethe stage. This staging system is used for most forms of cancer, except braintumors and hematological malignancies. Clinical stage is based on all of theavailable information obtained before a surgery to remove the tumor. Thus, itmay include information about the tumor obtained by physical examination, bloodtests,radiologicexamination, biopsy, andendoscopy.Pathologic stage adds additional information gained by examination of the tumormicroscopically by a pathologist after it has been surgically removed. Becausethey use different criteria, clinical stage and pathologic stage often differ.Pathologic staging is usually considered to be more accurate because it allowsdirect examination of the tumor in its entirety, contrasted with clinicalstaging which is limited by the fact that the information is obtained by makingindirect observations of a tumor which is still in the body. However, clinicalstaging and pathologic staging often complement each other.
Different factorsaffect a person’sprognosis.Some of the most important are the type and location of the cancer, the extentto which thecancerhasmetastasized, or spread and how abnormal the cancer cells look and how quicklythe cancer is likely to grow and spread. In addition, for cancers of the bloodor bone marrow such asleukemias andlymphomas, the presence of chromosomal abnormalities andabnormalities in the patient’s complete blood count can affect a person’sprognosis. Researchers usually give survival statistics as rates. The ratesdescribe the percentage of people with a specific cancer type who will be alivea certain time after diagnosis. Survival rates can describe any given length oftime.
Cancer screening aimsto detect cancer before symptoms appear. This may involve blood tests, urinetests, other tests, ormedical imaging.The benefits of screening in terms of cancer prevention, early detection andsubsequent treatment must be weighed against any harm.Universal screening,mass screening or population screening involves screening everyone, usuallywithin a specific age group. Selective screening identifies people who areknown to be at higher risk of developing cancer, such as people with a familyhistory ofcancer.Screening can lead to false positive results and subsequent invasiveprocedures. Screening can also lead to false negative results, where anexisting cancer is missed. Controversy arises when it is not clear if thebenefits of screening outweigh the risks of the screening procedure itself, andany follow-up diagnostic tests and treatments.
Carcinogenesisis theformation of acancer,whereby normal cells are distorted into cancer cells. The process ischaracterized by changes at the cellular, genetic, and epigenetic levels andabnormal cell division, in some cancers developing a malignant mass. Celldivision is a physiological procedure that occurs in almost all tissues andunder a variety of circumstances. A mutagen is a physical or chemical agentthat changes the genetic material, usuallyDNA,of an organism and thus increases the frequency of mutations above the naturalbackground level. As many mutations can cause cancer, mutagens are thereforealso likely to be carcinogens, although not always necessarily.
Cancer paintreatmentpurposes to release pain with slight adverse treatment effects, allowing theperson a good quality of life and level of function and a relatively painlessdeath. Though 80-90 percent of cancer pain can be controlled, half of thepeople with cancer pain in the developed world and more than 80% of peoplethrough cancer worldwide receive less than best care.Cancerchangesover time, and pain managing needs to reflect this. Some different types oftreatment may be required as the disease progresses. Pain managers shouldclearly explain to the person the cause of the pain and the various treatmentpossibilities, and should consider, as well as drug therapy, directly modifyingthe underlying disease, raising the pain threshold, interrupting, destroying orstimulating pain pathways, and suggesting lifestyle modification.
Oncology Nursingand Care
TheOncology NursingCertificationCorporation offers several different options for board certification inoncological nursing. Certification is a voluntary process and certifies a nursetakes proper experience and knowledge of a specialty area and has keptup-to-date in his or her education. In this certification is of different waysthey are Basic, Specialty. It is granted for four years, after which it must berenewed by taking a recertification test or by earning a certain number of continuingeducation credits. To become certified, nurses must have an RN license, meetspecific eligibility criteria for nursing experience and specialty practice,and must pass a multiple-choice test.
Cell Signalingand Cancer Therapy
View original post here:
Best Oncology Conferences 2018 | Oncology Meetings USA …
- Report from Stat reveals the limits of IBM's Watson for Oncology. - Slate Magazine (blog) - September 7th, 2017
- Merck snaps up a German immuno-oncology upstart in a $603M bolt ... - Endpoints News - September 7th, 2017
- Startup that makes personalized cancer treatments gets $93 million in funding - SFGate - September 7th, 2017
- Moonlight Mixer to benefit oncology services - AdVantage News - September 7th, 2017
- Ramping back up on oncology, GSK takes an option on Adaptimmune's TCR cancer drug - Endpoints News - September 7th, 2017
- Advanced oncology treatment now available in Sterling - Journal Advocate - September 7th, 2017
- Ransomware Attack May Impact 19K Oncology Hematology Patients - HealthITSecurity.com - September 7th, 2017
- Zymeworks to Present at the European Society for Medical Oncology 2017 Congress and Hold Webcast to Review ... - Business Wire (press release) - September 6th, 2017
- OSE Immunotherapeutics Partners with Oncology Physician Network GERCOR to Conduct a Combination Phase 2 ... - Business Wire (press release) - September 6th, 2017
- MEI Pharma nabs rights to oncology candidate voruciclib - Seeking Alpha - September 5th, 2017
- EnGeneIC Announces Publication in The Lancet Oncology of First Clinical Study Employing EDV Nanocell Platform ... - Markets Insider - September 5th, 2017
- Performance by comedian David Lee Nelson raises money for oncology center - Do Savannah - September 5th, 2017
- Pembrolizumab Has Promising Activity in Extensive-Stage SCLC - Cancer Network - September 5th, 2017
- Endocyte Announces Presentation at the European Society for Medical Oncology (ESMO) - GlobeNewswire (press release) - September 5th, 2017
- 19000 Medical Oncology Hematology Consultants, PA records exposed in ransomware attack - SC Magazine - September 4th, 2017
- Belgian Biotech Grows its Immuno-Oncology Pipeline for Childhood Cancer - Labiotech.eu (blog) - September 4th, 2017
- Innovations in oncology explode as new treatments gain approval - Business Day (registration) - September 4th, 2017
- Cancer center takes in Houston patients statewide following Hurricane Harvey - KVUE - September 4th, 2017
- Oncology the current landscape and what it means for the future - pharmaphorum - September 4th, 2017
- To Fight Cancer, India Must Fast-Track Approvals For Oncology Drugs And Devices - Huffington Post India - September 4th, 2017
- Therapeutic Area: Oncology | Chiltern - September 3rd, 2017
- Texas Oncology to cancer patients who have been displaced by ... - Star Local Media - September 3rd, 2017
- Oncurious to Buy VIB's Immun-Oncology Portfolio - BioPharm International - September 2nd, 2017
- Delaware oncology group hit by nearly month-long ransomware attack - Healthcare IT News - September 2nd, 2017
- For residents, by residents: Mentorship program focuses on radiation oncology - Radiology Business - September 2nd, 2017
- Gilead Sciences' Oncology M&A Strategy Explained - Motley Fool - September 2nd, 2017
- Performance of AstraZeneca's Oncology Segment in 2Q17 - Market Realist - September 2nd, 2017
- Shattuck-Takeda Partnership Will Involve Double-barreled Cancer-fighting Therapies - Immuno-Oncology News - September 2nd, 2017
- Guenther Koehne named chief of bone marrow transplantation and hematologic oncology at Miami Cancer Institute - The Cancer Letter Publications - September 2nd, 2017
- Pharmalittle: A generic rival for opioid treatment & an oncology setback for J&J - STAT - September 2nd, 2017
- BeiGene Announces Presentations at the European Society for Medical Oncology 2017 Congress - GlobeNewswire (press release) - August 31st, 2017
- Loxo Oncology to Present at Upcoming Investor Conferences - GlobeNewswire (press release) - August 31st, 2017
- 6 years after child's death, father buys lunch for oncology unit nurses - WKRN.com - August 31st, 2017
- Pediatric oncology nurses embrace a unique role - Atlanta Journal Constitution - August 31st, 2017
- AVEO Oncology: EU Approval Pop Is Just The Beginning - Seeking Alpha - August 31st, 2017
- BizVibe Announces Its List of the Best Oncology Pharmaceutical Companies for 2017 - Business Wire (press release) - August 31st, 2017
- ZIOPHARM Oncology Inc (ZIOP) Shares Needle Moving -2.94% - Morgan Research - August 31st, 2017
- Star team quietly raises $21M to launch the latest immuno-oncology ... - Endpoints News - August 31st, 2017
- Texas Oncology Available To Patients Impacted By Harvey - PR Newswire (press release) - August 30th, 2017
- Dell Medical School creates Department of Oncology - UT The Daily Texan - August 30th, 2017
- Six years after child's death, father buys lunch for oncology unit ... - NBC4i.com - August 30th, 2017
- Jazz, ImmunoGen partner on hematology, oncology drug development - BioPharma Dive - August 30th, 2017
- Five Prime cuts loose from InhibRx immuno-oncology deal - FierceBiotech - August 29th, 2017
- Bivarus and Community Oncology Alliance Collaborate to Improve ... - Business Wire (press release) - August 29th, 2017
- Kura Oncology to Participate in Citi's 12th Annual Biotech Conference - GlobeNewswire (press release) - August 29th, 2017
- Exceptional Registered Nurse and Radio Oncology Nurse, Jose Vicente Delgado, RN, BSN, will be Highlighted in the ... - PR NewsChannel (press release) - August 29th, 2017
- Unusual Activity Spotted in ZIOPHARM Oncology Inc (ZIOP) and Telecom Argentina SA (TEO) - Morgan Research - August 29th, 2017
- Oncology training for community nurses begin in Kumasi - Ghana News Agency - August 29th, 2017
- AVEO Oncology (AVEO) Granted European Union Approval for FOTIVDA (tivozanib) - StreetInsider.com - August 28th, 2017
- Ridley-Tree Cancer Center of Santa Barbara achieves four-year accreditation for radiation oncology services from ... - Markets Insider - August 28th, 2017
- Immuno-Oncology 360 Summit Confirms Program Line-up for February 7-9, 2018 - Benzinga - August 28th, 2017
- Options Traders Expect Huge Moves in ZIOPHARM Oncology (ZIOP) Stock August 28, 2017 - Zacks.com - August 28th, 2017
- Park Ridge news briefs: Oncologist, molecular biologist named to Maine South's alumni Wall of Honor - Chicago Tribune - August 28th, 2017
- 'Bras for a Cause' to benefit oncology patients - Sandusky Register - August 27th, 2017
- Oncology | Internal Medicine | ACP - August 26th, 2017
- Maury Regional adds five physicians - Columbia Daily Herald - August 26th, 2017
- Friday, August 25, 2017 - LWW Journals (blog) - August 26th, 2017
- Who Is Cancer Genetics? - Modest Money (press release) (blog) - August 25th, 2017
- Oncology probe was blocked - Independent Online - August 25th, 2017
- Samaritan awarded radiation oncology qualification for new cancer treatment option - WatertownDailyTimes.com - August 25th, 2017
- Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient ... - PR Newswire (press release) - August 25th, 2017
- Highlighting the hematology/oncology unit at Gundersen - News8000.com - WKBT - August 25th, 2017
- FDA Actions & Updates - LWW Journals (blog) - August 24th, 2017
- Equicare Health and Lexington Medical Center collaborate on oncology integration project - Markets Insider - August 24th, 2017
- A Look into Merck's Immunology and Oncology Portfolio - Market Realist - August 24th, 2017
- Hematologist Oncologist Now Serving Mid-Shore Cancer Patients - My Eastern Shore - August 24th, 2017
- Grid Therapeutics Signs Exclusive License Agreement to Develop a Novel Immuno-Oncology Antibody - Business Wire (press release) - August 22nd, 2017
- LabCorp Partners OmniSeq to Grow in Immuno-Oncology Space ... - Nasdaq - August 22nd, 2017
- BTG and SIO Expand Immuno-Oncology / Interventional Oncology Grant Programme - Markets Insider - August 21st, 2017
- Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient ... - Markets Insider - August 21st, 2017
- ZIOPHARM Oncology Inc (ZIOP) Share Performance Recap - FLBC News - August 19th, 2017
- Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop ... - Markets Insider - August 19th, 2017
- Teton Valley Hospital to provide oncology services - KIFI - LocalNews8.com - August 19th, 2017
- Is ZIOPHARM Oncology Inc (ZIOP) Building Momentum? - FLBC News - August 19th, 2017
- Can Stress Cause Cancer? | Massage Professionals Update - August 18th, 2017
- Champions Oncology (CSBR) Announces Research Pact with The Addario Lung Cancer Medical Institute - StreetInsider.com - August 18th, 2017
- Buy or Sell? Average Brokerage Ratings on Vantiv, Inc. (VNTV), Clovis Oncology, Inc. (CLVS) - StockNewsJournal - August 18th, 2017
- Bristol-Myers shares sink after another setback for its immuno-oncology franchise drugs - Endpoints News - August 18th, 2017
- Cell Line Development Services Markets, 2025 - Growing Incidence Rates of Oncology and Immunological Disorders ... - GlobeNewswire (press release) - August 18th, 2017
- Advanced oncology treatment now available in Sterling - Fort Morgan Times - August 17th, 2017